CVS Health has increased its full-year profit forecast and announced plans to exit the Obamacare health insurance market by 2026. Under CEO David Joyner, the company has implemented cost-cutting ...

Shares of CVS Health Corporation (CVS) traded 10% higher in pre-market on Thursday after the company reported better-than-expected first-quarter (Q1) earnings and raised its full-year profit guidance.

(Reuters) -CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health insurance plans in 2026, as it seeks to turn around its fortunes ...

CVS Health boosts its full-year profit expectations following robust quarterly results, indicating a rebound from last year's struggles. The company attributes its success to cost-cutting measures, ...

(Reuters) -CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signalling an early recovery after a series of troubles hit the ...

CVS Health reported stronger-than-expected earnings and revenue for the first quarter Thursday, raising its full-year guidance as improvement in its insurance business helped ease investor concerns.

CVS Health hiked its 2025 forecast above Wall Street's expectations after improving Medicare benefits contributed to a better-than-expected first quarter.

Pharmacy retail company CVS Health ( NYSE: CVS) is scheduled to announce its first quarter earnings result on Thursday, May 1st, before the opening bell. The company is expected to report earnings per ...

CVS raises profit forecast, to exit Obamacare market as turnaround ... insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare ...

It reduced its holdings by 3.75 million shares, just days after the healthcare conglomerate raised its annual forecast and beat Wall Street estimate for quarterly profit. CVS had been facing pressure ...

CVS shares jumped 5% to $69.84 after it raised its 2025 profit forecast to $6 to $6.20 per share from $5.75 to $6 previously. CEO David Joyner, who took the helm of the healthcare conglomerate in ...